In 1960, Alphonse Chapanis turned his attention from engineering to healthcare. He dedicated himself to studying medication errors, having identified seven sources of errors with potential harm to the patient, including medicine omitted, or given to the wrong patient, at the wrong dose, as an unintended extra dose, by the wrong route, at the wrong time, or as the wrong drug entirely. [1] Sixty years later, many of these errors are still often detected in clinical practice. Drug safety is not a static concept. Over the years, the (wrong) perception that medicines were safe when made available to the population has changed, causing some therapeutic catastrophes, like the thalidomide tragedy in the 1960s. Damage caused by medication can be considered as the ''dark side'' of drug therapy. Whenever a decision is made to use medications for a particular patient, it is intended that the benefit outweigh the inherent risk. For that, it is necessary to be aware of all types of harm that can be inflicted on patients, so that strategies can be adopted to minimize it. This editorial will focus on three strategies for (1) medication errors, (2) adverse drug reactions (ADR), and (3) look-alike-soundalike (LASA) medicines. Medication errors are defined as any preventable incident that can cause harm to the patient or lead to inappropriate use of medicines, when these are under the control of healthcare professionals or patients. These incidents can be related to professional practices, to the products themselves, or to the processes, and include failures in prescription, communication, labelling, packaging, denomination, preparation, distribution, dispensing, administration, education, monitoring, and use of medicines. [2] In other words, a medication error will be any preventable incident that occurs by action or omission at any stage of the medication use process and that may or may not cause harm to the patient. The